Ameritas Investment Partners, Inc. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$15,995
-16.3%
14,8100.0%0.00%0.0%
Q2 2023$19,105
-2.3%
14,8100.0%0.00%0.0%
Q1 2023$19,549
-27.9%
14,8100.0%0.00%0.0%
Q4 2022$27,102
+59.4%
14,8100.0%0.00%0.0%
Q3 2022$17,000
+6.2%
14,8100.0%0.00%0.0%
Q2 2022$16,000
-63.6%
14,8100.0%0.00%
-50.0%
Q1 2022$44,000
+12.8%
14,8100.0%0.00%
+100.0%
Q4 2021$39,000
-27.8%
14,8100.0%0.00%
-50.0%
Q3 2021$54,000
-15.6%
14,8100.0%0.00%0.0%
Q2 2021$64,000
+25.5%
14,8100.0%0.00%0.0%
Q1 2021$51,000
-1.9%
14,8100.0%0.00%0.0%
Q4 2020$52,000
+44.4%
14,8100.0%0.00%0.0%
Q3 2020$36,000
+56.5%
14,810
+17.4%
0.00%
+100.0%
Q2 2020$23,000
+15.0%
12,6100.0%0.00%0.0%
Q1 2020$20,000
-25.9%
12,6100.0%0.00%0.0%
Q4 2019$27,000
+12.5%
12,6100.0%0.00%0.0%
Q3 2019$24,000
-27.3%
12,6100.0%0.00%
-50.0%
Q2 2019$33,000
+3.1%
12,6100.0%0.00%
+100.0%
Q1 2019$32,000
+10.3%
12,6100.0%0.00%
-50.0%
Q4 2018$29,000
-27.5%
12,6100.0%0.00%0.0%
Q3 2018$40,000
+11.1%
12,6100.0%0.00%0.0%
Q2 2018$36,000
-20.0%
12,6100.0%0.00%0.0%
Q1 2018$45,000
+12.5%
12,610
+21.4%
0.00%0.0%
Q4 2017$40,000
+53.8%
10,3900.0%0.00%
+100.0%
Q3 2017$26,000
-7.1%
10,3900.0%0.00%0.0%
Q2 2017$28,000
+12.0%
10,390
+36.9%
0.00%0.0%
Q1 2017$25,0007,5900.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders